Xylitol is commonly used as sugar substitute in households. While it has numerous beneficial effects on human health, it is highly toxic to dogs. The goal of this study was to examine whether xylitol has similar deleterious effects, such as hypoglycaemia and acute hepatic failure, on cats. Our research included six healthy middle-aged cats.
| INTRODUCTION
Xylitol is a 5-carbon sugar alcohol, and it can be consumed in chewing gums, candies, bakeries or even in medicines (Cortinovis & Caloni, 2016) . It has also been known that xylitol has antibacterial effect on the oral cavity; therefore, it is used in many dental products for humans (Peterson, 2013; Cock et al., 2016) . Furthermore, it reduced plaque and calculus accumulations when added to drinking water of cats (Clarke, 2006) . Xylitol is applied in various ways in households, thus companion animals, such as dogs and cats, can have a direct contact with this substance.
As it has been reported previously, xylitol is highly toxic in dogs (Schmid & Hovda, 2016) . Xylitol triggers β-cells of the pancreas to release insulin, which leads to a severe hyperinsulinaemia and consequent hypoglycaemia (Xia, He, & Yu, 2009 ). The early recognizable clinical signs include vomiting, lethargy and weakness. Ataxia and seizures can also be observed (Peterson, 2013) . Clinical signs appear usually within 30-60 min of ingestion, due to hypoglycaemia (Dunayer, 2004) . The clinical signs may progress rapidly from lethargy to ataxia, collapse and seizure, then hepatic failure (Dunayer & Gwaltney-Brand, 2006) , prolonged clotting times and thrombocytopenia can be diagnosed later (Kovalkovičová, Šutiaková, Pistl, & Šutiak, 2009 Peterson, 2013 . Severe xylitol toxicosis can have fatal consequences in dogs (Peterson, 2013) . Other common serum chemistry abnormalities include hypokalemia, due to insulin's property of moving potassium into the cell along with glucose (Church, 2005) and hypophosphatemia, as insulin can increase cellular permeability to the phosphate ion (Feldman, 2005) . However, hyperphosphatemia was a poor prognostic indicator (Dunayer & Gwaltney-Brand, 2006) . Xylitol ingestion can also induce hepatotoxicosis (Lee, 2015) , even liver necrosis. The precise mechanism has not been elucidated yet; however, it is assumed that the lack of adenosine triphosphate (ATP) causes necrosis in liver cells (Peterson, 2013) . The most reasonable way to confirm hepatic failure is to examine liver function test like bile acid and also liver enzymes like alanine aminotransferase (ALT) gamma-glutamyl transferase (GGT, alkaline phosphatase (ALKP) and glutamate dehydrogenase (GLDH) (Todd & Powell, 2007; Xia et al., 2009 ). Campbell and Bates reported that a lower than 100 mg/kg bw dose of xylitol can cause clinical signs in dogs rarely (Campbell & Bates, 2010) . However, ingestion of xylitol at 100 mg/kg bw can result in pronounced insulin release and hypoglycaemia, while at 500 mg/kg bw leads to hepatotoxicity and even death (Peterson, 2013) .
Xylitol poisonings in cats have not been published previously. The goal of our study was to describe the possible effects of xylitol ingestion in cats by monitoring their basic health status and alterations in their blood parameters, mainly focusing on blood glucose concentrations and blood biochemical parameters.
| MATERIALS AND METHODS

| Experimental animals
In our research, six cats (two British Shorthair cats and four European Shorthair), four neutered females and two neutered males, were included. They were housed in a 3 × 2.5 × 3 m sized cat kennel with environmental enrichment and fed with commercial dry food intended for neutered cats (Royal Canin Neutered Male and Female, Aimargues, France). During the treatment and handling, animals were placed in individual animal cages to help thorough observation. The animals were clinically healthy, middle-aged (between 2 and 6 years of age) and had average body condition score (BCS). The average weight of cats was 3.1 ± 0.39 kg. Cats were fasted for 12 hr before the initiation of the study. Intravenous catheters were inserted in each experimental animal to permit immediate assistance in case of potential toxic signs. 
| Administration of xylitol and study design
On Day 1, the lowest dose of xylitol-100 mg/kg bw-was administered p.o. to cats. Xylitol was dissolved in deionized water and administered via a syringe. Clinical status and blood glucose concentration were monitored closely. One drop of whole blood was taken from the ears of the cats with scratching with a sterile 23-G needle before and 10, 20, 30, 60, 120, 180, 240, 300 , 360 min and 24 hr after xylitol administration. Blood samples (5 ml) were taken from the jugular vein before and 6, 24 and 72 hr after xylitol administration and submitted to laboratory analysis (see below). Prior to the xylitol administration and every hour after, the basic clinical parameters, respiration frequency and heart rate, and capillary refill time (CRT) were noted. Special emphasis was laid on a basic neurological examination observing movement, gait, mental state, behaviour, head position, eyeball position, size and position of the pupils, pupillary light reflex, menace reflex, corneal reflex, palpebral reflex and also the knuckling over or correction reflex. Examination of the mucous membranes and abdominal palpation was carried out. As neither clinical nor laboratory signs confirmed any harmful effects of xylitol, after a 5-day washout period (altogether 8 days after the first dose), the same cats were used for the next 500 mg/kg dosage. Blood glucose monitoring was performed similarly, and blood samples were taken before and 6, 24 and 72 hr after xylitol application. After another 5-day washout phase, xylitol at 1,000 mg/kg was administered to the cats and blood samples were taken, under similar conditions.
| Blood sampling and laboratory analysis
Control blood samples were taken right before xylitol administration.
The measured complete blood count and biochemical parameters were normal in each animal before xylitol administration (Tables 1 and   2 ). Complete blood count (CBC) and blood biochemical parameters such as total protein (TP), albumin, alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALKP), glutamate dehydrogenase (GLDH), bile acid, blood urea nitrogen (BUN), creatinine, phosphate, sodium and potassium were measured in these control samples and after each treatment. Samples were taken into serum and K 2 EDTA blood collection tubes (BD Vacutainer, New Jersey, USA) from the jugular vein from each animal before and 6, 
| Statistical analysis
For statistical analysis, R 3.1.3 software package (2015) was applied.
Differences between means were evaluated by one-way analysis of variance (one-way ANOVA) with post hoc Tukey test, where data were of normal distribution, and homogeneity of variances was confirmed. Linear model was applied with ANOVA method to compare the blood parameters after xylitol ingestion to blood parameters before administration. No significant differences were established when p values were >.05.
| RESULTS
| Clinical examination
All cats involved in the study remained clinically healthy during the 
| Blood glucose concentrations
The blood glucose values were within reference ranges during the 
| Complete blood count and blood biochemical parameters
Complete blood counts (CBCs) were within reference ranges at all time points (results not shown) and not influenced by xylitol administration. Table 1 demonstrates the mean ± SD values of biochemical parameters after each applied dose of xylitol. There were no significant differences (p > .05) between total protein, albumin, ALT, ALKP, GGT, GLDH, bile acids, urea, creatinine, phosphate, sodium and potassium concentrations compared to the baselines prior to xylitol administration. In addition, it should be noted that all the examined biochemical parameters were within physiological reference range during the whole investigation. Bile acids were slightly elevated and above physiological reference range, but this was experienced also in control samples, before xylitol administration. No significant changes were observed in this parameter after xylitol administration (p > .05).
As no relevant changes were noted in ALT, ALKP, GGT, GLDH and bile acid levels, it appeared that xylitol had no hepatotoxic effect on our cats. To conclude that xylitol has no hepatotoxic effect on cats, further studies are needed in other cat populations as well.
| DISCUSSION
In human nutrition consumption of xylitol as sweetener seems to be safe, however, even low dose of this sweetener is considered harmful to dogs in which oral administration can cause severe hypoglycaemic clinical signs, liver failure and even death (Dunayer, 2006) .
So far, the effects of xylitol in cats have been unknown. The present research examined thoroughly the acute effects of p.o. administered xylitol in cats. Even a relatively high dose (1,000 mg/kg) did not lead to significant changes in blood glucose concentrations, compared to dogs, where blood glucose concentrations decrease within 30-60 min and insulin concentrations elevate within 20-40 min (Dunayer, 2006) .
During the whole study, blood glucose concentration values of cats remained in the physiological range. The reason for the different reaction in cats remains to be elucidated.
Several reports described hypokalaemia in dogs after oral ingestion of xylitol because of the high insulin concentration (Dunayer & Gwaltney-Brand, 2006; Kovalkovičová et al., 2009 ). In our research, the blood potassium concentrations did not show significant alteration.
Hepatic failure is a known consequence of xylitol ingestion in dogs. One possible mechanism is that xylitol and its metabolites deplete adenosine triphosphate (ATP) in the liver (Vincent, Van den Berghe, & Hers, 1989; Woods & Krebs, 1973) . Without adequate ATP values, the liver is unable to maintain normal cellular function, and cellular necrosis might result. Another mechanism may involve the production of reactive oxygen species that can damage cellular components (Bailey & Cunningham, 1998) . The blood biochemical parameters which refer to liver damage and function (ALT, ALKP, GGT, GLDH, albumin) did not show significant alterations from reference ranges after any dosage of xylitol applied in cats. Due to xylitolinduced hepatic necrosis in dogs, the liver enzymes and blood phosphate concentrations were increased and hepatic failure manifested within 9-72 hr (Dunayer & Gwaltney-Brand, 2006; Peterson, 2013) .
In our examinations, only a mild and nonsignificant elevation in GLDH concentration was observed after 1,000 mg/kg dose xylitol ingestion in cats. GLDH is a mitochondrial enzyme and has three known isoenzymes (GLUD1, GLUD2 and a plant GLDH). GLUD1 is expressed at high levels in liver, brain, pancreas and kidney, but not in muscle;
F I G U R E 1 Mean ± SD blood glucose concentrations (mmol/L) after xylitol administration in cats (n = 6). Three doses of xylitol were applied (100 mg/kg, 500 mg/kg and 1,000 mg/kg), and blood glucose concentrations were monitored prior to and 10, 20, 30 min, 1, 2, 3, 4, 5, 6 and 24 hr after xylitol consumption Mean blood glucose levels (mmol/L) Average blood glucose levels (100 mg/kg) Average blood glucose levels (500 mg/kg) Average blood glucose levels (1,000 mg/kg) GLUD2 in human retina, testis and, at a lower level, brain (Hascup et al., 2011; Shashidharan et al., 1994) . A third isoenzyme was found in plants (Marchi, Polverini, Degola, Baruffini, & Restivo, 2014) . Our GLDH values showed wide standard deviation, thus the statistic results were significant. Although GLDH and hyperinsulinism have close connection in humans (Tanizawa et al., 2002) , no marked alteration was found in our study, most probably due to normal concentrations of insulin after xylitol ingestion in cats.
The other blood biochemical parameters (urea, creatinine, phosphate, sodium, potassium) indicated physiological kidney function.
There were no significant alterations in the previously mentioned parameters after any dose of xylitol. Only potassium appears to slightly increase in the third group received 1,000 mg/kg of xylitol. However, this was insignificant and might be the result of the small number of animals involved. Increased phosphate and decreased potassium concentrations occur in dogs after xylitol ingestion, but these changes can also refer to high insulin concentrations and liver failure (Dunayer & Gwaltney-Brand, 2006) .
After xylitol ingestion of dogs, clinical signs are rapidly accompanied by lethargy, vomiting, ataxia, weakness, later seizures, coma and even death (Peterson, 2013) . We found that our cats' clinical status remained stable; there were no remarkable clinical signs after any dose of xylitol administration.
In a short-term period, negative effects cannot be observed in cats after xylitol ingestion. Xylitol does not lead to hepatopathy or kidney failure, and its application appears to be safe in cats similarly to that in humans (Natah, Hussien, Tuominen, & Koivisto, 1997) . It can be assumed that the toxicodynamics or the metabolism is different in cats, which can explain the lack of toxic or reactive materials harmful to the liver tissue or to the kidney, but further studies are necessary to be completed to reveal the precise mechanisms which can explain these interspecies variations.
| CONCLUSION
Based on the clinical examinations of each cat, oral ingestion of xylitol does not lead to any gastrointestinal problems, such as diarrhoea or vomiting. In addition, according to the detailed evaluation of blood samples, the values of liver enzymes and kidney parameters did not show any abnormalities. In conclusion, it can be reported that p.o. administered xylitol, even at the dosage up to 1,000 mg/kg, is not toxic in cats.
